β-adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: Restoration by L-arginine

Journal of Hypertension

Volumn 22, Issue 10, 2004, Pages 1917-1925

  Schlaich, Markus P ^a,b   Ahlers, Belinda A ^a   Parnell, Melinda M ^a   Kaye, David M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adrenoceptor agonists; Arginine; Endothelium; Essential hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ADULT; ARM BLOOD FLOW; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FOREARM; HUMAN; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 5044219577     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200410000-00014     Document Type: Article

References (39)

1. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27.
2. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995; 91:1732-1738.
3. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 1994; 23:1610-1616.
4. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330:1036-1040.
5. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915-918.
6. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 1997; 30:918-921.
7. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997; 95:2293-2297.
8. Majmudar NG, Anumba D, Robson SC, Ford GA. Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature. Br J Clin Pharmacol 1999; 47:173-177.
9. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995; 96:579-585.
10. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990; 85:647-652.
11. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998; 97:851-856.
12. Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE. Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol 1998; 31:359-365.
13. Taddei S, Virdis A, Mattei P, Arzilli F, Salvetti A. Endothelium- dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension. J Cardiovasc Pharmacol 1992; 20:S193-S195.
14. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1298-1303.
15. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17:151-183.
16. Chin-Dusting JP, Cameron JD, Dart AM, Jennings GL. Human forearm venous occlusion plethysmography: methodology, presentation and analysis. Clin Sci (Colch) 1999; 96:439-440.
17. Feldman RD. Beta-adrenergic receptor alterations in hypertension - physiological and molecular correlates. Can J Physiol Pharmacol 1987; 65:1666-1672.
18. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80:812-817.
19. McAllister RG Jr, Love DW, Guthrie GP Jr, Dominic JA, Kotchen TA. Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch Intern Med 1979; 139:879-881.
20. Bertel O, Buhler FR, Kiowski W, Lutold BE. Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980; 2:130-138.
21. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJ. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro. Clin Pharmacol Ther 1990; 48:87-95.
22. Leenen FH, Boer P, Dorhout Mees EJ. Peripheral beta-adrenoceptor responsiveness in young normotensive and hypertensive subjects. Clin Exp Hypertens 1981; 3:539-553.
23. Frohlich ED, Tarazi RC, Dustan HP. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med 1969; 123:1-7.
24. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91:1981-1987.
25. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-2155.
26. Fraser J, Nadeau J, Robertson D, Wood AJ. Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest 1981; 67:1777-1784.
27. Stein M, Deegan R, Wood AJ. Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation. Clin Pharmacol Ther 1993; 54:187-193.
28. Stein M, Deegan R, He H, Wood AJ. Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther 1993; 54:58-64.
29. Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension. J Hypertens 2002; 20:117-124.
30. Schlaich MP, Klingbeil A, Hilgers K, Schobel HP, Schmieder RE. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am Heart J 1999; 138:810-817.
31. Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000; 36:371-375.
32. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST. Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003; 546:583-589.
33. Kaye DM, Ahlers BA, Autelitano DJ, Chin-Dusting JP. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation 2000; 102:2707-2712.
34. Dawes M, Chowienczyk PJ, Ritter JM. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 2001; 134:939-944.
35. Chen YY, Doggrell SA. Responsiveness, affinity constants and beta-adrenoceptor reserves for isoprenaline on aortae from normo-, pre- and hypertensive rats. J Pharm Pharmacol 2002; 54:515-522.
36. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20:511-517.
37. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87:1475-1481.
38. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci (Lond) 1991; 81:695-700.
39. Rhodes P, Barr CS, Struthers AD. Arginine, lysine and ornithine as vasodilators in the forearm of man. Eur J Clin Invest 1996; 26:325-331.